To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
James LinderDr. James “Jim” Linder, MD, (born 1954) is president of UNeMed Corporation, the technology transfer entity of the University of Nebraska Medical Center, and is an American authority on university research commercialization.[1] A noted author, academic and business leader, Linder also serves as Associate Vice Chancellor for Research at UNMC, and is a professor of pathology and microbiology. He serves on editorial boards of several medical journals, and is a former president of the American Society for Clinical Pathology.[2] From 1995 to 2007 he was affiliated with Cytyc Corporation, a Massachusetts-based medical company dedicated to women's health. Additional recommended knowledge
Early lifeA native of Omaha, Linder earned his B.S. degree in biochemistry and microbiology from Iowa State University in 1976, and his M.D. degree, with distinction, from the University of Nebraska Medical Center in 1980. He completed his residency training in pathology at Duke University Medical Center and UNMC. Career highlightsIn January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.[3] Since 1995 he has worked with Cytyc Corporation, a women's health company located in Marlborough, Mass., and served as medical director from 2002-06.[4] A main area of interest has been improving Pap testing. He is a frequent guest lecturer, and has written five textbooks, including co-authoring the 10th edition of Anderson’s Pathology, a comprehensive two-volume reference for pathologists, residents and medical students.[5] He has written more than 130 professional articles.[6] He also serves on several editorial boards, including the American Journal of Clinical Pathology[7] and Modern Pathology.[8] From 1998-99, he was president of the American Society of Clinical Pathologists. He is a member and has served in leadership positions with many medical organizations, including the American Society of Cytopathology[9] and the U.S./Canadian division of the International Academy of Pathology.[10] He holds several patents, and his academic interests have focused on the application of technology in medical diagnostics, including immunochemistry, molecular diagnostics, computer-aided instruction, cellular imaging, and the use of automated techniques in cytopathology. Linder has served on the UNMC faculty since 1983 when he joined the Pathology and Microbiology Department. In 1986 he was named associate professor and in 1989 was named professor. He has held numerous administrative positions at UNMC, including vice chairman of pathology and microbiology, director of surgical pathology, director of cytopathology, and associate dean for academic affairs. He is currently Associate Vice Chancellor for Research, responsible for developing clinical research programs at UNMC and statewide.[11] He also served as visiting professor at the Peter Kiewit Institute. Awards, honors, community serviceLinder has been accorded many professional honors and awards. In 2005, he was presented with the American Society of Clinical Pathologists "Israel Davidsohn Award for Distinguished Service";[12] he was awarded the "Distinguished Teaching Award" by the UNMC College of Medicine and the "Award for Excellence in Medical Publications" from the American Medical Writers Association.[13] From 1999-2001, he served on the board of directors of the Omaha Children’s Museum, and has been a volunteer instructor at Roncalli High School in Omaha.[14] Personal and familyLinder is married to Karen Allen, a cytotechnologist and past president of the American Society for Cytotechnology,[15] and has three children. He enjoys martial arts, scuba diving, reading and art. References
|
||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "James_Linder". A list of authors is available in Wikipedia. |